Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes

被引：26

作者：

Vera, Juan F. ^{[1
,2
]}

Brenner, Malcolm K. ^{[1
,2
,4
]}

Dotti, Gianpietro ^{[1
,2
,3
]}

机构：

[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Methodist Hosp, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Med, Methodist Hosp, Houston, TX 77030 USA

[3] Baylor Coll Med, Dept Immunol, Methodist Hosp, Houston, TX 77030 USA

[4] Baylor Coll Med, Dept Pediat, Methodist Hosp, Houston, TX 77030 USA

来源：

CURRENT GENE THERAPY | 2009年 / 9卷 / 05期

关键词：

TUMOR-INFILTRATING LYMPHOCYTES; ENGINEERED DONOR LYMPHOCYTES; ORGAN TRANSPLANT RECIPIENTS; CHIMERIC RECEPTOR GENE; VIRUS-INDUCED LYMPHOMA; ANTITUMOR-ACTIVITY; ADOPTIVE TRANSFER; ANTIGEN RECEPTOR; CELL-RECEPTOR; SUICIDE-GENE;

D O I：

10.2174/156652309789753338

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Adoptive T cell therapies can produce objective clinical responses in patients with hematologic and solid malignancies. Genetic manipulation of T lymphocytes has been proposed as a means of increasing the potency and range of this anti-tumor activity. We now review how coupling expression of transgenic receptors with countermeasures against potent tumor immune evasion strategies is proving highly effective in pre-clinical models and describe how these approaches are being evaluated in human subjects.

引用

页码：396 / 408

页数：13

共 144 条

[1] IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
Ahmadzadeh, M
Rosenberg, ST
[J]. BLOOD, 2006, 107 (06) : 2409 - 2414
[2] Regression of experimental medulloblastoma following transfer of HER2-specific T cells
Ahmed, Nabil
Ratnayake, Maheshika
Savoldo, Barbara
Perlaky, Laszlo
Dotti, Gianpietro
Wels, Winfried S.
Bhattacharjee, Meenakshi B.
Gilbertson, Richard J.
Shine, H. David
Weiss, Heidi L.
Rooney, Cliona M.
Heslop, Helen E.
Gottschalk, Stephen
[J]. CANCER RESEARCH, 2007, 67 (12) : 5957 - 5964
[3] [Anonymous], 2006, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol, DOI DOI 10.1200/JCO.2006.05.9964
[4] Commercially available gas-permeable cell culture bags may not prevent anoxia in cultured or shipped islets
Avgoustiniatos, E. S.
Hering, B. J.
Rozak, P. R.
Wilson, J. R.
Tempelman, L. A.
Balamurugan, A. N.
Welch, D. P.
Weegman, B. P.
Suszynski, T. M.
Papas, K. K.
[J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (02) : 395 - 400
[5] Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor
Beecham, EJ
Ortiz-Pujols, S
Junghans, RP
[J]. JOURNAL OF IMMUNOTHERAPY, 2000, 23 (03): : 332 - 343
[6] Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
Berger, Carolina
Jensen, Michael C.
Lansdorp, Peter M.
Gough, Mike
Elliott, Carole
Riddell, Stanley R.
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (01) : 294 - 305
[7] Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells
Biagi, E
Yvon, E
Dotti, G
Amrolia, PJ
Takahashi, S
Popat, U
Marini, F
Andreeff, M
Brenner, MK
Rousseau, RF
[J]. HUMAN GENE THERAPY, 2003, 14 (06) : 545 - 559
[8] Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
Bollard, Catherine M.
Gottschalk, Stephen
Leen, Ann M.
Weiss, Heidi
Straathof, Karin C.
Carrum, George
Khalil, Mariam
Wu, Meng-fen
Huls, M. Helen
Chang, Chung-Che
Gresik, M. Victoria
Gee, Adrian P.
Brenner, Malcolm K.
Rooney, Cliona M.
Heslop, Helen E.
[J]. BLOOD, 2007, 110 (08) : 2838 - 2845
[9] Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
Bollard, CM
Rössig, C
Calonge, MJ
Huls, MH
Wagner, HJ
Massague, J
Brenner, MK
Heslop, HE
Rooney, CM
[J]. BLOOD, 2002, 99 (09) : 3179 - 3187
[10] Safety of retroviral gene marking with a truncated NGF receptor
Bonini, C
Grez, M
Traversari, C
Ciceri, F
Marktel, S
Ferrari, G
Dinauer, M
Sadat, M
Aiuti, A
Deola, S
Radrizzani, M
Hagenbeek, A
Apperley, J
Ebeling, S
Martens, A
Kolb, HJ
Weber, M
Lotti, F
Grande, A
Weissinger, E
Bueren, JA
Lamana, M
Falkenburg, JHF
Heemskerk, MHM
Austin, T
Kornblau, S
Marini, F
Benati, C
Magnani, Z
Cazzaniga, S
Toma, S
Gallo-Stampino, C
Introna, M
Slavin, S
Greenberg, PD
Bregni, M
Mavilio, F
Bordignon, C
[J]. NATURE MEDICINE, 2003, 9 (04) : 367 - 369

← 1 2 3 4 5 6 7 8 9 10 →